Gatc Health
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2030 Main St Ste 660, Irvine, California...Phone Number
(833) 333-4282Website
www.gatchealth.comRevenue
<$5 MillionIndustry
About Gatc Health
Gatc Health Org Chart
Is Gatc Health your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Gatc Health
Funding: Get notified immidiatlly once Gatc Health has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Gatc Health had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Gatc Health launches new products
Check if Gatc Health has recently received funding, and reach out quickly before it becomes old news!
Check out if Gatc Health is spiking on competitors!
Gatc Health, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Gatc Health recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Gatc Health as Masked Content
Find 2 more new buyers
Compare Similar Companies to Gatc Health
Compare insights from companies similar to Gatc Health, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gatc Health is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Gatc Health is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Gatc Health.
Gatc Health Tech Stack
A closer look at the technologies used by Gatc Health
Most Recent Scoops
Gatc Health News & Media
GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment
IRVINE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, and researchers from the University of California, Irvine (UCI) today announced the publication of a joint study in the Proceedings of the National Academy of Sciences (PNAS). The peer-reviewed paper validates a novel drug candidate, GATC-1021, which was identified using GATC Health’s Operon™ AI platform to more preciGATC Health Strengthens Commercial and Pharma Strategy Leadership to Accelerate Market Adoption of Its AI Platform
IRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- GATC Health, a leading tech-bio company leveraging AI to transform drug discovery and development, is proud to announce two strategic additions to its leadership team: Mark Flather as Senior Vice President of Business Development and Strategy, and Fred Brown as Senior Advisor, Pharma Partnerships & Strategy. The additions strengthen GATC’s commercial leadership as the company expands adoption of its Derisq™ AI risk prediction product and Operon™BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)
SAN DIEGO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, and GATC Health Corp. (GATC), a tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, today announced a SPV transaction to advance ozuriftamab vedotin (Oz-V) (CAB-ROR2-ADC) in a Phase 3 Study in 2L+ oropharynGATC Health to Host Virtual KOL Event to Discuss Derisq™ AI Report: Predictive, Detailed Risk Assessment of Drug Candidates, on December 10, 2025
BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announced that it will host a virtual key opinion leader (KOL) event on Wednesday, December 10, 2025 at 1:00 PM ET/10:00 AM PT. The event will feature Lin Yu, PhD (Former Managing Director, Oppenheimer Healthcare Investment Banking), Tomas Philipson, PhD (Former Acting Chairman, Council of Economic Advisers, Executive Office o
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gatc Health
GATC Health is a tech-bio company that utilizes proprietary AI technology to enhance the drug discovery and development process, aiming to make it safer and more effective for biopharma companies and their investors. Their Operon platform simulates human biochemistry to predict clinical outcomes, thereby assisting biotech and pharmaceutical compani... Read More
